Finance

Beta
Lists
IMMNOV:STO
Immunovia AB (publ)
0,20 SEK
+1,74%
(+0,0035) 1D
1-июн., 17:29:36 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for IMMNOV...
Open
0,20 SEK
High
0,20 SEK
Low
0,19 SEK
Mkt. cap
138,25 млн
Avg. vol.
6,21 млн
Volume
4,23 млн
52-wk high
0,75 SEK
52-wk low
0,15 SEK
EPS
-0,26 SEK
Shares outstanding
672,67 млн
No. of employees
15
Open
0,20 SEK
High
0,20 SEK
Low
0,19 SEK
Mkt. cap
138,25 млн
Avg. vol.
6,21 млн
Volume
4,23 млн
52-wk high
0,75 SEK
52-wk low
0,15 SEK
EPS
-0,26 SEK
Shares outstanding
672,67 млн
No. of employees
15
News stories
From sources across the web
About Immunovia AB (publ)
CEOJeff Borcherding
Employees15
Founded2007
Headquarters-
SectorMedical device
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
90,00 миң
101,00 миң
354,00 миң
424,00 миң
Cost of goods sold
-
36,00 миң
100,00 миң
143,00 миң
Cost of revenue
-
36,00 миң
100,00 миң
143,00 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,79 млн
24,67 млн
15,86 млн
17,88 млн
Operating expense
20,15 млн
25,12 млн
16,63 млн
18,72 млн
Total operating expenses
20,15 млн
25,15 млн
16,73 млн
18,86 млн
Operating income
-20,06 млн
-25,05 млн
-16,38 млн
-18,43 млн
Other non operating income
7,00 миң
1,00 миң
-69,00 миң
-
EBT including unusual items
-41,05 млн
-29,74 млн
-17,33 млн
-18,43 млн
EBT excluding unusual items
-41,05 млн
-29,74 млн
-17,33 млн
-18,43 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
34,00 миң
-
93,00 миң
816,00 миң
Net income
-41,05 млн
-29,74 млн
-17,33 млн
-18,43 млн
Net profit margin
-45 612,22%
-29 449,50%
-4 895,20%
-4 347,64%
Earnings per share
-14,00
-10,00
-0,03
-0,03
Interest and investment income
11,00 миң
11,00 миң
63,08 млн
-
Interest expense
-21,01 млн
-4,70 млн
-
-
Net interest expenses
-21,00 млн
-4,69 млн
63,08 млн
-
Depreciation and amortization charges
322,00 миң
450,00 миң
674,00 миң
17,00 миң
EBITDA
-19,74 млн
-24,60 млн
-15,70 млн
-18,42 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more